巨噬细胞膜修饰纳米颗粒治疗糖尿病心血管并发症的研究进展
Research progress on macrophage membrane nanoparticles in the treatment of diabetic cardiovascular complications
糖尿病心血管并发症是糖尿病患者死亡的主要原因之一。近年来,纳米颗粒药物递送系统在药物递送领域展现出显著优势,尤其在感染性疾病、癌症以及心血管疾病等疾病治疗中展现出巨大潜力。其中巨噬细胞膜修饰纳米颗粒凭借其出色的免疫逃逸能力和炎症靶向特性,显著增加药物在病变组织的富集,使其成为心血管并发症治疗研究的新方向。本文就巨噬细胞膜修饰纳米颗粒的仿生特性、作用机制及其在糖尿病心血管并发症治疗中的最新研究进展做一综述。重点探讨了该技术在调控炎症反应、缓解氧化应激以及改善内皮功能等方面的机制。旨在为开发针对糖尿病心血管并发症的精准治疗策略提供新的思路。
Diabetic cardiovascular complications are one of the main causes of death in diabetic patients. In recent years, nanoparticle drug delivery systems have shown significant advantages in the field of drug delivery, especially in the treatment of infectious diseases, cancer and cardiovascular diseases. Among them, macrophage membrane nanoparticles significantly increase the enrichment of drugs in diseased tissues by virtue of their excellent immune escape ability and inflammatory targeting characteristics, making them a new direction for the treatment of cardiovascular complications. This article reviews the bionic characteristics, mechanism of action of macrophage membrane nanoparticles and the latest research progress in the treatment of diabetic cardiovascular complications. The mechanism of this technology in regulating the inflammatory response, alleviating oxidative stress and improving endothelial function was discussed. The aim is to provide new ideas for the development of precise treatment strategies for diabetic cardiovascular complications.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
刘刚, 刘明宇, 李修靖, |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
Zhou H, Wu Y, Li M, |
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
谢环, 杨雪瑶, 宋俊华, |
国家自然科学基金面上项目(82370457)
/
| 〈 |
|
〉 |